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Increased life expectancy is usually associated with comorbidities, such as cardio and
cerebrovascular disease causing impaired functionality. A common underlying cause of
these comorbidities is vascular inflammation and injury. Elevated levels of circulating
microvesicles (cMV), as a product of a hemostatic and inflammatory cell activation,
could be direct mapping of an imbalanced hemostasis. In this manuscript, we aimed
to investigate by liquid biopsy whether successful aging can be discriminated by
cMV levels and phenotype. To this purpose, we included 135 community-dwelling
octogenarians in a cross-sectional study. Successful aging was defined as good
functional (Barthel Index > 90 points, and Lawton index score > 7/4 points for
women and men, respectively) and cognitive status (Spanish version of the Mini-
Mental State Examination -MEC- > 24 points) and no need for institutionalization.
Total, annexin V positive (AV+), and AV− cMV from different cell origins from the
vascular compartment were phenotypically characterized and quantified from fasting
plasma samples by flow cytometry. Successful aging was associated with lower
plasma concentrations of total and AV+ CD141+/CD41+-CD61+, and PAC1+/AV+,
CD141+/AV+, and CD36+/AV− cMV. From these phenotypes, ROC curve analyses
revealed that CD141+/AV+ and CD141+/CD41+-CD61+/AV+ endothelial- and platelet-
derived cMV discriminate successful and non-successful aging with an AUC (95%CI) of
0.655 (0.551, 0.758), P = 0.005, and 0.638 (0.535, 0.741), P = 0.013, respectively. In
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conclusion, successful aging is associated with low levels of cMV released by endothelial
cells and platelets, indicating lower endothelial cell inflammation and platelet activation.
Our results contribute to the understanding of the link between unsuccessful aging,
cognitive decline and vascular cell inflammatory disturbances.
Keywords: circulating microvesicles, octogenarians, successful aging, cognitive decline, inflammation, platelet
activation, thrombomodulin, endothelial cells
INTRODUCTION
Successful aging can be defined as growing old in optimum
conditions (von Faber et al., 2001), considering the fact that
increased life expectancy is usually associated with comorbidities,
impaired functionality (Mitra et al., 2020), and diminished
quality of life (Formiga et al., 2011). The 2018 Aging Report
from the European Union confirms that the European population
is continuously aging in a significant manner (European
Commission [EC], 2018). Although life expectancy may be
currently affected by the COVID pandemic (Trias-Llimós and
Bilal, 2020), hopefully in a passing manner, the old age-related
dependency is expected to increase in more than 20% in 2070
(European Commission [EC], 2018).
Non-successful aging is associated with higher risk of
malnutrition and falls, frailty, and with higher co-morbidity,
and more specifically with cardiovascular disease (CVD) and
cerebrovascular disease (Formiga et al., 2011; Beauchet et al.,
2020), with vascular damage as a common underlying cause.
In fact, it is of paramount importance to reduce the incidence
of major vascular events such as coronary heart disease or
stroke, in order to prevent cognitive and functional decline, or
even disability.
Circulating microvesicles (cMV) are membrane blebs ranged
0.1–1 µm extruded from almost all types of cells after activation,
injury or apoptosis. cMV contain bioactive molecules that can
modulate the phenotype of target recipient cells by paracrine
regulation (Gnecchi et al., 2006; Badimon et al., 2019). Indeed,
cMV can bind and activate endothelial cells, that by recruiting
platelets and leukocytes and inducing smooth muscle cell
proliferation, may overall enhance vascular inflammation and
damage (Daniel et al., 2006; Dalli et al., 2013; Hulsmans and
Holvoet, 2013). Elevated concentrations of cMV have been
observed after a stroke (Chiva-Blanch et al., 2016) or coronary
heart disease (Chiva-Blanch et al., 2017a), and are believed to
be both the cause and consequence of atherosclerosis. We have
recently observed that frail older adults also show elevated levels
of cMV from platelets and leukocytes (Arauna et al., 2020).
Therefore, specific cMV phenotypes from blood and vascular
cells associated with non-successful aging, may be candidate
biomarkers of age-related cognitive and functional impairment.
These may help in the research of prognostic biomarkers
indicators of overall functional and cognitive decline in the
future, and may help in the identification of subjects requiring
specific strategies to prevent vascular dysfunction at the onset of
cognitive and functional decline.
Previously, we observed that older octogenarians with non-
successful aging had altered levels in plasma of proteins related
to inflammation and coagulation, which were directly associated
with cognitive status, cardiovascular event presentation (Cubedo
et al., 2015) and increased cardiovascular mortality at 5 years
follow-up (Cubedo et al., 2017). Considering the biological link
between aging, vascular damage, cognitive decline and functional
performance, and the worldwide importance of successful
aging in the society, the aim of our study is to investigate
whether successful aging is related to a lower activation of




In this cross-sectional study, we included 135 community-
dwelling octogenarians from the OCTABAIX (Oldest
CharacTheristic and Assessments-Baix Llobregat) cohort
(Ferrer et al., 2010; Badia et al., 2015) at baseline (registered at
clinicaltrials.gov with the reference NCT01141166). Inclusion
criteria, as per protocol, were to be born in 1924 and not being
institutionalized (24 h of professional care available). Therefore,
all subjects were 85 years old at the year of inclusion (2009).
Exclusion criteria in this sub-study was having a cardiovascular
event within the last year. In addition, samples with repeated
freeze/thaw cycles and hemolyzed samples were also excluded
(Supplementary Figure 1). All samples were processed within
October-November 2019.
Functional, cognitive and nutritional status were assessed
with questionnaires currently used in geriatric practice. Barthel
Index was performed to measure the functional capacity for
basic activities of daily living; Lawton Index was administered
to evaluate the ability to carry out instrumental activities; and
the Spanish version of the Mini-Mental State Examination
(MEC) was performed to assess cognitive impairment. In the
three test, the higher the score, the higher the functionality
and independence. Subjects with Barthel Index scores > 90
were classified as functional independent. Women with Lawton
Index scores > 7 and men with scores > 4, respectively,
(Graf, 2008), were considered able for instrumental activities,
and subjects above 24 points in the MEC score showed
minimal cognitive impairment. Nutritional status was evaluated
with the mini-nutritional assessment (MNA), and scores below
23.5 were classified as malnutrition or at risk. Successful
aging was defined as good functional (Barthel Index > 90
points, and Lawton Index scores > 7 for women and >4
men) and cognitive status (MEC > 24 points), and no need
for institutionalization (Formiga et al., 2011). Non-successful
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aging was further categorized in having one, two or three
scores below good functional and/or cognitive status (Barthel
Index ≤ 90 points, Lawton Index scores ≤ 7 for women
and ≤4 men, and/or MEC ≤ 24 points). Medical data
were primarily obtained from general practice records, and
interviews were performed at primary care services. Subjects
signed an informed consent before inclusion in the study,
and all procedures were conducted in accordance with the
Declaration of Helsinki.
Blood Sampling
Fasting venous blood was withdrawn using a 20-gage needle,
and blood was collected into EDTA-treated tubes. Blood cells
were removed by centrifugation (1,500 × g, 15 min) at room
temperature (RT). Plasma was carefully aspirated, and 250 µL
aliquots of EDTA-anticoagulated plasma were immediately
frozen and stored at−80◦C until processing.
Laboratory Measurements





Circulating microvesicles were quantified as previously (Chiva-
Blanch et al., 2019, 2020; Arauna et al., 2020) and currently
described in Supplementary Material. Briefly, cMV were isolated
from 250 µL plasma by differential centrifugation and were
triple-label stained with Annexin V (AV, which has high
affinity for phosphatidylserine) and two specific monoclonal
antibodies (Supplementary Table 1) labeled with fluorescein
isothiocyanate (FITC) or phycoerythrin (PE), prior flow
cytometric analyses in a FACSCanto II (BD Biosciences). Flow
cytometry controls are shown in Supplementary Figure 2.
cMV were phenotypically characterized for bioactive and/or
biomarker molecules from their parental cells and were
defined as total cMV (AV±), AV+, or AV−, according
to phosphatidylserine exposure (Supplementary Figure 3).
Phosphatidylserine exposure promotes thrombin generation and
thrombus formation. Therefore, AV+ cMV present higher
prothrombotic activity than platelets (Sinauridze et al., 2007).
Statistical Analyses
Sample size was determined with the ENE 3.0 statistical program
(GlaxoSmithKline, Brentford, United Kingdom) assuming a loss
of 0% participants because samples were already collected.
We estimated that to recognize as statistically significant a
difference in the number of PAC-1+/AV+ cMV of 5 units
(MV)/µL plasma with a conservative SD of 6, we needed 19
and 28 subjects per group (successful and non-successful aging),
accepting an alpha risk of 0.05 and a beta risk of 0.2 in a
two-sided test, and considering the proportion of successful
aging around 0.30 of the population (Formiga et al., 2011).
Although PAC-1+/AV+ was used to determine sample size,
all cMV phenotypes tested were considered primary outcomes.
Therefore, to ensure sufficient power for the other outcomes
and to ensure sufficient statistical power to control for potential
confounders, the sample size was nearly doubled according to
sample availability (Supplementary Figure 1).
Statistical analyses were performed using the SPSS Statistical
Analysis System (version 23.0). Results are expressed as
mean ± SD, mean + SEM, or n (%) when indicated.
Normality of variables was assessed with the Shapiro–Wilk
test, and all variables followed a non-parametric distribution.
Therefore, non-parametric analyses were conducted. To analyze
differences according to functional and cognitive status or
successful aging, Mann–Whitney test for two independent
samples (for the comparison between successful and non-
successful aging), or the Kruskal–Wallis test for K independent
samples (for the comparison between different degrees of non-
successful aging) were carried out. Multiple comparisons were
performed with the Bonferrroni post hoc test. Multivariable
models for successful aging were performed with logistic
regression models (conventional and stepwise) with cMV from
different cell origins and phenotypes adjusting by potential
confounders in two different models. The first model, was
adjusted by previous CVD (yes/no), psychotropics (yes/no) and
MNA > 23.5, according to stepwise regression. The second
model was further adjusted by sex, dyslipidemia (yes/no), statins
(yes/no), and antiplatelet agents (yes/no), factors known to
modulate MV release (Badimon et al., 2019), and with existing
significant differences between groups. Receiver operating
characteristic (ROC)-curve estimations were performed, and
their corresponding C statistics [area under the curve (AUC) with
their 95% CI] were calculated for cMV phenotypes associated




Table 1 depicts the clinical characteristics of the subjects
according to their aging success. Subjects with a successful aging
were women in a lower percentage, showed higher levels of
HDL cholesterol and the renal function was more preserved
than in non-healthy aged subjects. No differences in the levels
of circulating leukocytes, platelets, hemoglobin, transaminases,
albumin, total protein, thyroid stimulating hormone or tiroxin
4 were observed between subjects with and without successful
aging (not shown).
As expected, and as per definition, subjects with a successful
aging scored higher in the Barthel and Lawton indexes, and
MEC and MNA scores compared to non-successfully aged
subjects. Consequently, a higher proportion of subjects with
successful aging were classified as functionally independent
(Barthel Index > 90), able to conduct instrumental activities
(Lawton Index > 7 or 4 for women and men, respectively), with
high cognitive performance (MEC score > 24), and/or adequately
nourished (MNA scores ≥ 24).
Subjects who reported non-successful aging had a higher
incidence of previous CVD (heart failure and stroke).
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TABLE 1 | Characteristics of the 85-year old subjects included in the study according to successful aging.
Non-successful aging (n = 87) Successful aging (n = 48) P1 P2
First degree (n = 28) Second degree (n = 23) Third degree (n = 36)
Females [n (%)] 22 (78.6) 18 (78.3) 23 (63.9) 24 (50.0) 0.009 0.033
Systolic blood pressure (mmHg) 136.68 ± 16.57 137.52 ± 16.59 135.14 ± 20.74 137.56 ± 16.68 0.591 0.932
Diastolic blood pressure (mmHg) 72.43 ± 10.84 71.04 ± 9.33 70.64 ± 11 71.4 ± 11.17 0.874 0.938
BMI (Kg/m2) 28.76 ± 5.48 28.22 ± 4.83 29.85 ± 3.99 28.58 ± 4.12 0.226 0.498
Glucose (mmol/L) 5.37 ± 1.48 5.56 ± 1.85 5.81 ± 1.82 5.83 ± 0.98 0.498 0.567
HbA1C (%) 6.35 ± 1.58 6.01 ± 1.06 6.08 ± 0.91 5.89 ± 0.56 0.393 0.303
Triglycerides (mmol/L) 1.35 ± 0.56 1.56 ± 0.64 1.32 ± 0.57 1.24 ± 0.6 0.056 0.216
Total cholesterol (mmol/L) 5.12 ± 1.14 5.09 ± 1.26 4.66 ± 0.75 5.24 ± 0.85 0.069 0.053
HDL cholesterol (mmol/L) 1.48 ± 0.34 1.32 ± 0.4 1.39 ± 0.3 1.62 ± 0.45 0.002 0.009
LDL cholesterol (mmol/L) 3.03 ± 1.03 3.08 ± 1.17 2.67 ± 0.67 3.06 ± 0.73 0.218 0.165
Tobacco consumption [n (%)] 0.151 0.183
Current smokers 1 (3.6) 1 (4.34) 0 (0) 0 (0)
Former smokers 3 (10.7) 3 (13.0) 10 (27.8) 15 (31.2)
Creatinin (mg/dL) 77.82 ± 19.26 100.35 ± 62.2 101.86 ± 31.45 82.75 ± 20.91 0.019 0.008
Glomerular filtration (mL/min) 57.42 ± 7.02 52.94 ± 14.6 51.04 ± 10.37 58.22 ± 5.72 0.005 0.002
Functional, cognitive and nutritional indexes
BARTHEL 93.04 ± 6.43 72.61 ± 24.58 62.36 ± 27.03 98.54 ± 2.3 <0.0001 <0.0001
BARTHEL > 90 16 (57.1) 2 (8.7) 0 (0) 48 (100) <0.0001 <0.0001
LAWTON 6.07 ± 1.72 3.78 ± 2.13 1.89 ± 1.7 6.9 ± 1.37 <0.0001 <0.0001
LAWTON > 7 (women) 14 (63.4) 3 (16.7) 0 (0) 24 (100) <0.0001 <0.0001
LAWTON > 4 (men) 4 (66.7) 0 (0) 0 (0) 24 (100) <0.0001 <0.0001
MEC 28.18 ± 4.78 26.3 ± 5.47 16.08 ± 5.49 31.29 ± 2.76 <0.0001 <0.0001
MEC > 24 22 (78.6) 18 (78.2) 0 (0) 48 (100) <0.0001 <0.0001
MNA 25.38 ± 1.88 20.78 ± 4.04 22.29 ± 2.9 26.74 ± 2.95 <0.0001 <0.0001
MNA > 23.5 24 (85.7) 7 (30.4) 13 (36.1) 43 (89.6) <0.0001 <0.0001
Dyslipidemia [n (%)] 13 (46.4) 11 (47.8) 14 (38.9) 8 (16.7) 0.002 0.014
Diabetes [n (%)] 10 (35.7) 6 (26.1) 19 (52.8) 12 (25.0) 0.126 0.075
Years of evolution 13 ± 8.33 16 ± 8.29 13.89 ± 5.47 8.58 ± 4.4 0.027 0.075
History of CVD [n (%)] 11 (39.3) 15 (65.2) 32 (88.9) 12 (25.0) <0.0001 <0.0001
Myocardial infarction 3 (10.7) 5 (21.7) 10 (27.8) 6 (12.5) 0.234 0.205
Heart failure 4 (14.3) 12 (52.2) 8 (22.2) 2 (4.2) 0.001 <0.0001
Peripheral vascular disease 1 (3.6) 1 (4.3) 5 (13.9) 1 (2.1) 0.16 0.125
Stroke 4 (14.3) 9 (39.1) 16 (44.4) 4 (8.3) 0.001 <0.0001
Atrial fibrillation 4 (14.3) 5 (21.7) 7 (19.4) 3 (6.25) 0.052 0.221
Chronic renal failure [n (%)] 0 (0) 3 (13.0) 3 (8.3) 3 (6.25) 0.885 0.298
Medication [n (%)]
Psychotropic 9 (32.1) 16 (69.6) 21 (58.3) 12 (25.0) 0.002 <0.0001
Cardiac dysrhythmia medication 3 (10.7) 5 (21.7) 6 (16.7) 6 (12.5) 0.574 0.671
Statins 14 (50) 10 (43.5) 18 (50) 11 (22.9) 0.004 0.034
ACE Inhibitors 16 (57.1) 10 (43.5) 17 (47.2) 14 (29.2) 0.023 0.098
Angiotensin-II receptor blockers 2 (7.1) 4 (17.4) 14 (38.9) 8 (16.7) 0.386 0.012
β- Blockers 8 (28.6) 5 (21.7) 11 (30.6) 6 (12.5) 0.044 0.193
α- Blockers 0 (0) 0 (0) 8 (22.2) 7 (14.6) 0.34 0.009
Calcium channel blockers 4 (14.3) 8 (34.8) 14 (38.9) 6 (12.5) 0.023 0.013
Diuretics 18 (64.3) 16 (69.6) 22 (61.1) 22 (45.8) 0.037 0.19
Antiplatelet agents 10 (35.7) 9 (39.1) 21 (58.3) 9 (18.7) 0.009 0.003
Oral anticoagulant therapy 3 (10.7) 4 (17.4) 8 (22.2) 4 (8.3) 0.154 0.289
Oral Antidiabetic agents 8 (28.6) 4 (17.4) 8 (22.2) 7 (14.6) 0.243 0.498
Insulin 2 (7.1) 4 (17.4) 4 (11.1) 0 (0) 0.015 0.048
P1 for the comparison between successful and non-successful aging (Mann–Whitney test or Chi-squared test), and P2, for the comparison between successful aging
and different degrees of non-successful aging (Kruskal–Wallis test or Chi-squared test). Successful aging was defined as good functional (Barthel Index > 90 points,
and Lawton Index scores > 7 for women and >4 men) and cognitive status (MEC > 24 points), and no need for institutionalization. Non-successful aging was further
categorized in having one (first degree), two (second degree), or three scores (third degree) below good functional and/or cognitive status (Barthel Index ≤ 90 points,
Lawton Index scores ≤ 7 for women and ≤4 men, and/or MEC ≤ 24 points). Glomerular filtration was calculated with the Modification of Diet in Renal Disease formula
(MDRD). BMI indicates body mass index; HDL, high density lipoprotein; LDL, low density lipoprotein; MNA, mini-nutritional assessment; MEC, Spanish version of the
Mini-Mental State Examination; CVD, cardiovascular disease; and ACE, angiotensin-converting-enzyme.
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Consequently, these subjects were in more proportion
under statins, β- blockers, calcium channel blockers, and
antiplatelet therapies. In addition, a higher percentage of
subjects who reported non-successful aging were under
psychotropic medication.
MV- Functional, Cognitive and Nutritional
Status
Subjects with a Barthel index score > 90 (n = 66), indicating
functional independence, showed lower levels of platelet-,
endothelial-, immune cell-, and erythrocyte- derived total,
AV+ or AV− cMV compared to dependent subjects (Barthel
score ≤ 90, n = 69; P ≤ 0.049, all), as can be observed in
Supplementary Figure 4.
Individuals with a Lawton index score > 7 for women and
>4 for men (n = 69), indicating ability for instrumental activities,
presented lower levels of platelet-derived total and AV+ GPVI+
and CD36+/GPVI+ cMV compared to subjects with a significant
degree of disability (n = 66), as illustrated in Supplementary
Figure 5 (P ≤ 0.042, all).
In the same line, octogenarians with a MEC score < 24
(n = 47), indicating cognitive impairment, showed higher
concentrations of platelet-derived total and AV+ CD36+/GPVI+
and GPVI+/AV+ cMV; and CD9+/AV− and CD36+/AV− cMV
compared to subjects with MEC scores≥ 24 (n = 88), as depicted
in Supplementary Figure 6 (P ≤ 0.034, all).
Supplementary Figure 7 shows that subjects with or at risk of
malnutrition (MNA ≤ 23.5; n = 48) show higher concentrations
of platelet-derived total, AV+ and AV− cMV compared to
FIGURE 1 | cMV levels according to successful aging in the 135 octogenarians included in the study. Results are shown as mean + SEM of concentrations of: (A)
total microvesicles; (B) AV+ microvesicles; and (C) AV− microvesicles. Successful aging (n = 48) was defined as good functional (Barthel Index > 90 points, and
Lawton Index scores > 7 for women and >4 men) and cognitive status (MEC > 24 points), and no need for institutionalization. Non-successful aging (NSA, n = 87)
was further categorized in having one (NSA-1, n = 28), two (NSA-2, n = 23), or three scores (NSA-3, n = 36) below good functional and/or cognitive status (Barthel
Index ≤ 90 points, Lawton Index scores ≤ 7 for women and ≤4 men, and/or MEC ≤ 24 points). AV indicates annexin V and cMV, circulating microvesicles. Used
markers for MV phenotyping are shown in Supplementary Table 1. Columns with different superscript letters indicate significant differences (P < 0.05, Bonferroni
post hoc test).
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subjects with MNA scores≥ 24 (n = 87), P≤ 0.047, all, indicating
platelet hyperreactivity in this situation. On the other hand,
subjects with MNA ≤ 23.5 showed lower concentrations of
immune cell-derived total CD9+ and CD9+/AV+, and higher
concentrations of CD40+/AV+ and CD16+/AV− cMV compared
to subjects adequately nourished (P ≤ 0.043, all), suggesting
altered immune functionality in subjects with malnutrition.
No significant associations were found between all other
MV phenotypes determined and functional, cognitive and
nutritional status.
MV- Successful Aging
Endothelial-derived CD31+/CD41a− (P = 0.044), and
CD31+/CD41a−/AV− (P = 0.028); platelet-derived CD141+
/CD41+-CD61+ (P = 0.009), CD141+/CD41+-CD61+/AV−
(P = 0.004), CD36+/GPVI+ (P = 0.024), and P2RY12+ (P =
0.032); as well as CD141+ (P = 0.033), CD36+/AV− (P = 0.029),
and CD40+ (P = 0.004) cMV concentrations were lower in
subjects who reported a successful aging. Moreover, AV+ cMV
from platelet origin [CD41+-CD61+/CD141+/AV+ (P = 0.009)
and CD36+/GPVI+/AV+ (P = 0.045)], and CD141+/AV+ (P =
0.006) cMV, were also lower in subjects who reported a successful
aging, compared to those subjects non-successfully aged. As
depicted in Figure 1, when non-successful aging was divided
in three degrees of severity, increasing concentrations of total
(Figure 1A), AV+ (Figure 1B), and AV− (Figure 1C) cMV from
platelet origin are observed, according to the severity of cognitive
and functional impairment.
As shown in Table 2, after multivariate-adjustments by sex,
dyslipidemia, previous CVD, psychotropics, statins, antiplatelet
agents, and MNA > 23.5, total and AV+ CD141+/CD41+-
CD61+, and PAC1+/AV+, CD141+/AV+, and CD36+/AV−
cMV remained inversely associated with successful aging.
From these phenotypes, ROC curve analyses revealed that
CD141+/AV+ and CD141+/CD41+-CD61+/AV+ endothelial-
and platelet-derived cMV modestly but significantly discriminate
successful and non-successful aging with an AUC (95%CI) of
0.655 (0.551, 0.758), P = 0.005, and 0.638 (0.535, 0.741) P = 0.013,
respectively, (Figure 2), considering non-successful aging as the
state of the variable. However, when both phenotypes were
considered together in the ROC analyses, there was no significant
improvement for the discrimination between successful and non-
successful aging AUC (95%CI): 0.656 (0.554, 0.759), P = 0.005. No
associations were found between successful aging and all other
MV phenotypes determined (Supplementary Table 2).
DISCUSSION
In this cross-sectional study, we have reported an inverse
association between successful aging and elevated concentrations
of cMV from platelets and endothelial cells in dwelling-
community octogenarians. To our knowledge, this is the first
time that the link between successful aging and cell activation,
through the quantification of cMV release at the bloodstream,
has been reported.
TABLE 2 | Association between cMV from different phenotypes and
successful aging.
B (95% CI) P
Total cMV
CD141+/CD41+-CD61+
Unadjusted 0.006 (0002, 0.010) 0.003
Multivariate-adjusted1 0.003 (0.000, 0.007) 0.038
Multivariate-adjusted2 0.003 (0.000, 0.007) 0.039
GPVI+
Unadjusted 0.008 (0.000, 0.016) 0.056
Multivariate-adjusted1 Not included in the stepwise model
Multivariate-adjusted2 0.006 (0.000, 0.012) 0.088
AV+ cMV
PAC-1+/AV+
Unadjusted 0.048 (0.009, 0.086) 0.016
Multivariate-adjusted1 0.044 (0.014, 0.073) 0.004
Multivariate-adjusted2 0.046 (0.017, 0.076) 0.002
CD141+/AV+
Unadjusted 0.004 (0.001, 0.007) 0.014
Multivariate-adjusted1 0.002 (0.000, 0.005) 0.035
Multivariate-adjusted2 0.002 (0.000, 0.005) 0.047
CD141+/CD41+-CD61+/AV+
Unadjusted 0.006 (0.002, 0.010) 0.003
Multivariate-adjusted1 0.003 (0.000, 0.007) 0.045
Multivariate-adjusted2 0.003 (0.000, 0.007) 0.043
GPVI+/AV+
Unadjusted 0.020 (−0.010, 0.051) 0.191
Multivariate-adjusted1 Not included in the stepwise model
Multivariate-adjusted2 0.020 (−0.005, 0.045) 0.109
CD36+/GPVI+/AV+
Unadjusted 0.025 (−0.006, 0.056) 0.114
Multivariate-adjusted1 Not included in the stepwise model
Multivariate-adjusted2 0.019 (−0.006, 0.043) 0.129
AV− cMV
CD141+/CD41+-CD61+/AV−
Unadjusted 0.056 (−0.005, 0.117) 0.071
Multivariate-adjusted1 Not included in the stepwise model
Multivariate-adjusted2 0.022 (−0.027, 0.071) 0.378
PAC-1+/CD62P+/AV−
Unadjusted 0.307 (0.064, 0.549) 0.014
Multivariate-adjusted1 Not included in the stepwise model
Multivariate-adjusted2 0.195 (0.000, 0.389) 0.050
CD36+/AV−
Unadjusted 0.01 (0.005, 0.017) 0.001
Multivariate-adjusted1 0.011 (0.006, 0.015) <0.0001
Multivariate-adjusted2 0.011 (0.006, 0.016) <0.0001
Results are expressed as B coefficient of regression with its 95% confidence interval
[B (95% CI)]. P from the regression model unadjusted, and 1adjusted by previous
CVD (yes/no), psychotropics (yes/no) and MNA > 23.5, according to stepwise
regression; and 2adjusted by sex, previous CVD (yes/no), psychotropics (yes/no)
and MNA > 23.5, dyslipidemia (yes/no), statins (yes/no), and antiplatelet agents
(yes/no). AV indicates annexin V and cMV, circulating microvesicles. Used markers
for MV phenotyping are shown in Supplementary Table 1. Successful aging was
defined as good functional (Barthel Index > 90 points, and Lawton Index scores > 7
for women and >4 men) and cognitive status (MEC > 24 points), and no need
for institutionalization. Non-successful aging was categorized in having one, two
or three scores below good functional and/or cognitive status (Barthel Index ≤ 90
points, Lawton Index scores≤ 7 for women and≤4 men, and/or MEC≤ 24 points).
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FIGURE 2 | ROC Receiver operating characteristic (ROC)-Curve analysis for
successful aging discrimination. ROC curve analyses revealed that
CD141+/AV+ (discontinued black line), and CD141+/CD41+-CD61+/AV+
(gray line) endothelial- and platelet-derived circulating microvesicles (cMV)
discriminate successful and non-successful aging with an AUC (95%CI) of
0.655 (0.551, 0.758), P = 0.005, and 0.638 (0.535, 0.741) P = 0.013,
respectively. Black continuous line is the reference line of the ROC curve
(AUC = 0.5). AV indicates annexin V. Used markers for MV phenotyping are
shown in Supplementary Table 1.
Elevated concentrations of cMV from platelets and
endothelial cells have been found in subjects after a major
cardiovascular event such as an acute myocardial infarction
(Chiva-Blanch et al., 2017b, 2019) or stroke (Lee et al., 2012;
Chiva-Blanch et al., 2016). These major adverse cardiovascular
events are known to cause an important decline in functional
and cognitive performance, or even disability because of the lack
of oxygen supply. In fact, and as expected, subjects with previous
CVD had significantly lower functional, cognitive and nutritional
scores compared to subjects free of major adverse cardiovascular
events at 85 years old (data not shown). Vascular dysfunction is
closely associated with dementia, especially in the oldest (van der
Flier et al., 2018). In fact, cerebral amyloid angiopathy, large and
lacunar infarcts, micro and large hemorrhages, microaneurysms,
perivascular space dilation, and arteriosclerosis predict vascular
cognitive impairment (Skrobot et al., 2016), and such situations
have also been linked to increased MV release from platelets,
endothelial cells and leukocytes (Badimon et al., 2019; Castillo
et al., 2019). Given the interrelationship between CVD and
cMV, and CVD and functional and cognitive performance,
it seems biologically plausible that lower scores of functional
and cognitive tests might be associated with high levels of
cMV. However, if elevated cMV are the result of cognitive
dysfunction (vascular cognitive impairment), or one of its causes
still remains unknown.
We have observed that subjects with low functional and
cognitive performance, quantified by Barthel and Lawton
Indexes and MEC score, show increased levels of cMV
with prothrombotic phenotype (AV+) derived from platelets,
and cMV not exposing PS (AV−) from platelets, endothelial
cells, leukocytes and erythrocytes. In addition, cMV carrying
thrombomodulin (CD141), both exposing AV or not, are also
in lower concentrations in successfully aged octogenarians.
This might be important on the grounds that, besides playing
an essential role in coagulation, thrombomodulin has been
shown to participate in the regulation of inflammatory processes
(Conway, 2012). Consistent with these results, subjects who
suffered a stroke show elevated concentrations of cMV from
platelets, endothelial cells, erythrocytes and leukocytes with
a prothrombotic phenotype at the long term (Chiva-Blanch
et al., 2016). Patients with Alzheimer disease and cognitive
decline show increased levels of neural-derived MV of specific
phenotypes (Kapogiannis et al., 2019; Eren et al., 2020), which
are able to identify Alzheimer-related cognitive decline again
at the long term. Additionally, we have previously observed
in a Chilean cohort that frail older adults present elevated
concentrations of total, AV+ and AV− cMV derived from
monocytes, natural killers and platelets (Arauna et al., 2020),
which contributes explaining, at least in part, the increased risk of
CVD in these subjects. In the same line, in another subset of the
OCTABAIX cohort, subjects with previous CVD and cognitive
decline presented higher concentrations of the antifibrinolytic
proteins alpha-2-antiplasmin (A2AP) and coagulation factor
XIII-B-chain (FXIIIB) compared to non-CVD subjects with
preserved cognition and functionality (Cubedo et al., 2015).
This was accompanied with a coordinated imbalance in several
proteins related to inflammation and coagulation (Cubedo et al.,
2017), pinpointing the association between cytokine-triggered
inflammation and vascular microthrombosis in unhealthy aging,
with CVD and cognitive impairment as underlying causes. In
this setting, it is plausible, therefore, that elevated concentrations
of cMV from platelets and endothelial cells with both AV+ and
AV− phenotypes contribute to the pathological state associated
with non-successful aging (cognitive impairment, CVD and
diminished quality of life).
In our study subjects, malnutrition scores were associated
with high platelet MV release and low immune cell-derived MV
blebbing, suggesting that malnutrition might be associated with
platelet hyperreactivity and immune dysfunction. However, data
on dietary intake and physical activity was not available, and
therefore this association requires further research.
The study of the effects of (non-successful) aging is primarily
focused on tissues and cells, and the effects of aging in circulating
factors is largely unexplored. After multivariate adjustments,
and although B coefficients are low, we have observed that
octogenarians successfully aged also show lower concentrations
of cMV from platelets and endothelial cells non-exposing
phosphatidylserine in their surface, thus with lower potential
prothrombotic effect. This observation fits the inflammaging
theory (Santoro et al., 2020), which attributes to subclinical
and chronic low-grade inflammation, that may be perpetuated
by sustained elevated concentrations of proinflammatory cMV,
an underlying cause of aging. In fact, senescent cells have
been shown to have a proinflammatory secretome (Eitan et al.,
2017; Takasugi, 2018) with increased release of MV and overall
extracellular vesicles (Willis et al., 2020) with proinflammatory
phenotypes (Alibhai et al., 2020; Salminen et al., 2020),
contributing to age-related comorbidities (Misawa et al., 2020).
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However, these studies have been performed in in vitro or in
in vivo models of aging (Russell et al., 2020; Salminen et al., 2020),
and human data is lacking.
In this study, successful aging has been defined as good
functional (Barthel Index > 90 points, and Lawton Index
scores ≤ 7 for women and ≤4 men) and cognitive status
(MEC > 24 points) and no need for institutionalization (Formiga
et al., 2011). However, this definition of successful aging has been
criticized (Laplante, 2014), because wellbeing and perception
of successful aging may not be limited to elders with full
functionality and independence (Golja et al., 2020), or “healthy”
from a strictly biomedical/clinical perspective, and may not
consider the individual feeling, social aspects (Ding et al., 2020),
depression, quality of life (Jang, 2020), or the “disability paradox”
(Albrecht and Devlieger, 1999). It is of course more likely that
disabled elders do not report successful aging, yet still some
elders with some degrees of disability may report wellness (Mitra
et al., 2020), especially those enclosed in aging services systems
facilitating their risk reduction of chronic diseases associated with
aging and promoting social inclusion. In this setting, successful
aging may be better defined and understood including qualities
and capacities appreciated in the elderly.
This study is not exempt of limitations. It is a cross-
sectional study of associative nature and therefore hypothesis-
generating. Further studies are needed to evaluate the causality
or consequence of elevated concentrations of cMV in functional
and cognitive performance. In addition, data on age of CVD
onset, and data on other comorbidities such as neurodegenerative
diseases or cancer are lacking. However, it is unlikely that
subjects with advanced Alzheimer disease or with a tumoral
process, for instance, or within the acute phase of a major
adverse cardiovascular event are not being institutionalized.
Samples used in this study belong to a biobank, and have
been carefully stored under −80◦C for 10 years. This might
provoke an unknown impact on MV stability. However,
samples were carefully processed. They were collected and
immediately frozen in aliquots in 2009, and were processed
and analyzed within 3 months in 2019. All samples were
handled following the same procedure and all samples were
frozen and thawed only for one specific analysis, in this case
the MV analysis. Therefore, the potential effects of long-term
effects of storage at −80◦C in MV stability is comparable
and homogeneous between samples. Finally, the lower limit
of detection of the cytometer used for cMV quantification
is between 0.2 and 0.3 µm. Therefore, information on
extracellular vesicles from smaller sizes are missing and might
be of relevance.
In summary, our study shows an inverse association between
endothelial- and platelet-derived cMV release at the bloodstream
and higher scores in functional and cognitive tests reflecting
successful aging. Our results contribute in the accumulating
evidence of the link between unsuccessful aging, cognitive
decline and vascular inflammation and damage, determined
here as elevated circulating levels of MV from platelets and
endothelial cells at the bloodstream. To our knowledge and
as previously mentioned, this is the first study associating low
concentrations of platelet- and endothelial cell-derived cMV
with successful aging, which opens new future lines of research,
such as, for instance, the evaluation of the potential of cMV
in adulthood as predictive biomarker of successful aging, from
a holistic and comprehensive perspective, in the late elderly,
or the identification of subjects requiring specific strategies
to prevent vascular dysfunction and the onset of cognitive
and functional decline, in order to modulate the rate of non-
successful aging.
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